Literature DB >> 26884933

Lentiviral vector PLV-PI3KCG gene transfer inhibits hypoxic cardiomyocytes apoptosis.

Yan-Yan Li1, Hui Zhang2, Xin-Zheng Lu3.   

Abstract

The PI3K/Akt signal pathway was suggested to be associated with apoptosis. However, it was still unclear whether activated PI3K/Akt signaling pathway could inhibit hypoxic cardiomyocytes apoptosis. In this research, the recombinant PI3KCG lentiviral vector plasmid (PLV-PI3KCG) was constructed and transfected into neonatal rat hypoxia/reoxygenation (H/R) injury cardiomyocytes models which were randomly divided into five groups as the normal control group, H/R group, HR empty plasmid group (HRE group), HR PLV-PI3KCG transfection preconditioning group (HRP group), and HR PLV-PI3KCG transfection + LY294002 group (HRPL group). Compared with the H/R, HRE and HRPL groups, the cardiomyocytes beat frequency and survival rate in the HRP group were significantly increased (P<0.05) and the released LDH were significantly decreased (P<0.05). The Bcl-2/Bax ratio was significantly lower in H/R, HRE and HRPL groups than that in HRP group (P<0.05). Activated PI3K/Akt signaling pathway could play a protection role in the cardiomyocytes H/R injury process which could be inhibited by LY294002.

Entities:  

Keywords:  Lentiviral vector; PI3KCG; cardiomyocytes; hypoxia/reoxygenation; virus packaging

Year:  2015        PMID: 26884933      PMCID: PMC4723778     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.

Authors:  Carol O'Brien; Jeffrey J Wallin; Deepak Sampath; Debraj GuhaThakurta; Heidi Savage; Elizabeth A Punnoose; Jane Guan; Leanne Berry; Wei Wei Prior; Lukas C Amler; Marcia Belvin; Lori S Friedman; Mark R Lackner
Journal:  Clin Cancer Res       Date:  2010-05-07       Impact factor: 12.531

2.  Preconditioning: is the Akt-ion in the PI3K pathway?

Authors:  Elizabeth Murphy; Haiyan Tong; Charles Steenbergen
Journal:  J Mol Cell Cardiol       Date:  2003-09       Impact factor: 5.000

Review 3.  Taming the PI3K team to hold inflammation and cancer at bay.

Authors:  Emilio Hirsch; Elisa Ciraolo; Alessandra Ghigo; Carlotta Costa
Journal:  Pharmacol Ther       Date:  2008-03-05       Impact factor: 12.310

4.  Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways.

Authors:  Chunmei Li; Jingwei Tian; Guisheng Li; Wanglin Jiang; Yanli Xing; Jian Hou; Haibo Zhu; Hong Xu; Guanbo Zhang; Zhifeng Liu; Zuguang Ye
Journal:  Eur J Pharmacol       Date:  2010-09-20       Impact factor: 4.432

5.  Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer.

Authors:  Jeffrey J Wallin; Jane Guan; Wei Wei Prior; Kyle A Edgar; Robert Kassees; Deepak Sampath; Marcia Belvin; Lori S Friedman
Journal:  Sci Transl Med       Date:  2010-09-08       Impact factor: 17.956

6.  Simvastatin activates Akt/glycogen synthase kinase-3beta signal and inhibits caspase-3 activation after experimental subarachnoid hemorrhage.

Authors:  Gao Cheng; Wang Chunlei; Wu Pei; Liu Zhen; Liu Xiangzhen
Journal:  Vascul Pharmacol       Date:  2009-12-18       Impact factor: 5.773

7.  TRAF6-mediated regulation of the PI3 kinase (PI3K)-Akt-GSK3beta cascade is required for TNF-induced cell survival.

Authors:  Kwiyeom Yoon; Eun Joo Jung; Soo Young Lee
Journal:  Biochem Biophys Res Commun       Date:  2008-04-11       Impact factor: 3.575

Review 8.  Stem cell therapy in ischemic heart disease.

Authors:  Julia N E Sunkomat; Mohamed A Gaballa
Journal:  Cardiovasc Drug Rev       Date:  2003

9.  Isoform-specific phosphoinositide 3-kinase inhibitors exert distinct effects in solid tumors.

Authors:  Kyle A Edgar; Jeffrey J Wallin; Megan Berry; Leslie B Lee; Wei Wei Prior; Deepak Sampath; Lori S Friedman; Marcia Belvin
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations.

Authors:  W Yuan; E Stawiski; V Janakiraman; E Chan; S Durinck; K A Edgar; N M Kljavin; C S Rivers; F Gnad; M Roose-Girma; P M Haverty; G Fedorowicz; S Heldens; R H Soriano; Z Zhang; J J Wallin; L Johnson; M Merchant; Z Modrusan; H M Stern; S Seshagiri
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

View more
  3 in total

1.  LncRNA260-specific siRNA targeting IL28RA gene inhibit cardiomyocytes hypoxic/reoxygenation injury.

Authors:  Ge Gong; Xin-Xing Yang; Yanyan Li; Hong-Yu Geng; Zhi-Jian Yang; Lian-Sheng Wang; Hyun Jun Kim; Xin-Zheng Lu
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

2.  Protective effects of IL28RA siRNA on cardiomyocytes in hypoxia/reoxygenation injury.

Authors:  Ge Gong; Yanyan Li; Xinxing Yang; Hongyu Geng; Xinzheng Lu; Liansheng Wang; Zhijian Yang
Journal:  Anatol J Cardiol       Date:  2017-06-22       Impact factor: 1.596

3.  Protective effects of PI3KCG gene on acute myocardial infarction.

Authors:  Ge Gong; Xin-Xing Yang; Yan-Yan Li; Hong-Yu Geng; Hui Wang; Lian-Sheng Wang; Zhi-Jian Yang
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.